Elemental fluorine to 8-fluoropurines in one step

Journal of the American Chemical Society

Volumn 118, Issue 43, 1996, Pages 10408-10411

  Barrio, Jorge R ^a   Namavari, Mohammad ^a   Phelps, Michael E ^a   Satyamurthy, Nagichettiar ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANOFLUORINE DERIVATIVE; PURINE DERIVATIVE;

ARTICLE; DRUG SYNTHESIS; FLUORINATION; NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS;

EID: 0029799813     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja961456c     Document Type: Article

References (67)

1. (a) Walsh, C. In Advances in Enzymology; Meister, A., Ed.; John Wiley and Sons: New York, 1983; Vol. 55, p 197.
2. (b) Welch, J. T. Tetrahedron 1987, 43, 3123.
3. (c) Selective Fluorination in Organic and Bioorganic Chemistry; Welch, J. T., Ed.; American Chemical Society: Washington. DC, 1991.
4. (d) Barnette, W. E. CRC Crit. Rev. Biochem. 1984, 15, 210.
5. Marquez, V. E.; Tseng, C, K.-H.; Mitsuya, H.; Aoki, S.; Kelley, J. A.; Ford, H., Jr.; Roth, J. S.; Broder, S.; Johns, D. G.; Driscoll, J. S. J. Med. Chem. 1990, 33, 978.
6. Silverman, R. B. in Mechanism-Based Enzyme Inactivation: Chemistry and Enzymology: CRC Press, Inc.: Boca Raton, FL, 1988; Vol. I, p 59.
7. See, for example: (a) Robins M. J.; Uznanski, B. Can. J. Chem. 1981, 59, 2608. (b) Montgomery, J. A.; Shortnacy, A. T.; Secrist, J. A., III J. Med. Chem. 1983, 26, 1483. (c) Secrist, J. A., III; Shortnacy, A. T.; Montgomery, J. A. J. Med Chem. 1985, 28, 1740. (d) Secrist, J. A., III; Bennett, L. L., Jr.; Allan, P. W.; Rose, L. M.; Chang, C. H.; Montgomery, J. A. J. Med. Chem. 1986, 29, 2069. (e) Secrist, J. A., III; Shortnacy, A. T.; Montgomery, J. A. J. Med. Chem. 1988, 31, 405.
8. See, for example: (a) Robins M. J.; Uznanski, B. Can. J. Chem. 1981, 59, 2608. (b) Montgomery, J. A.; Shortnacy, A. T.; Secrist, J. A., III J. Med. Chem. 1983, 26, 1483. (c) Secrist, J. A., III; Shortnacy, A. T.; Montgomery, J. A. J. Med Chem. 1985, 28, 1740. (d) Secrist, J. A., III; Bennett, L. L., Jr.; Allan, P. W.; Rose, L. M.; Chang, C. H.; Montgomery, J. A. J. Med. Chem. 1986, 29, 2069. (e) Secrist, J. A., III; Shortnacy, A. T.; Montgomery, J. A. J. Med. Chem. 1988, 31, 405.
9. See, for example: (a) Robins M. J.; Uznanski, B. Can. J. Chem. 1981, 59, 2608. (b) Montgomery, J. A.; Shortnacy, A. T.; Secrist, J. A., III J. Med. Chem. 1983, 26, 1483. (c) Secrist, J. A., III; Shortnacy, A. T.; Montgomery, J. A. J. Med Chem. 1985, 28, 1740. (d) Secrist, J. A., III; Bennett, L. L., Jr.; Allan, P. W.; Rose, L. M.; Chang, C. H.; Montgomery, J. A. J. Med. Chem. 1986, 29, 2069. (e) Secrist, J. A., III; Shortnacy, A. T.; Montgomery, J. A. J. Med. Chem. 1988, 31, 405.
10. See, for example: (a) Robins M. J.; Uznanski, B. Can. J. Chem. 1981, 59, 2608. (b) Montgomery, J. A.; Shortnacy, A. T.; Secrist, J. A., III J. Med. Chem. 1983, 26, 1483. (c) Secrist, J. A., III; Shortnacy, A. T.; Montgomery, J. A. J. Med Chem. 1985, 28, 1740. (d) Secrist, J. A., III; Bennett, L. L., Jr.; Allan, P. W.; Rose, L. M.; Chang, C. H.; Montgomery, J. A. J. Med. Chem. 1986, 29, 2069. (e) Secrist, J. A., III; Shortnacy, A. T.; Montgomery, J. A. J. Med. Chem. 1988, 31, 405.
11. See, for example: (a) Robins M. J.; Uznanski, B. Can. J. Chem. 1981, 59, 2608. (b) Montgomery, J. A.; Shortnacy, A. T.; Secrist, J. A., III J. Med. Chem. 1983, 26, 1483. (c) Secrist, J. A., III; Shortnacy, A. T.; Montgomery, J. A. J. Med Chem. 1985, 28, 1740. (d) Secrist, J. A., III; Bennett, L. L., Jr.; Allan, P. W.; Rose, L. M.; Chang, C. H.; Montgomery, J. A. J. Med. Chem. 1986, 29, 2069. (e) Secrist, J. A., III; Shortnacy, A. T.; Montgomery, J. A. J. Med. Chem. 1988, 31, 405.
12. (a) Robins M. J.; Naik, S. R. J. Am. Chem. Soc. 1971, 93, 5277.
13. (b) Robins, M. J.; MacCoss, M.; Naik, S. R.; Ramani. G. J. Am. Chem. Soc. 1976, 98, 7381.
14. (c) Gerstenberger, M. R. C.; Haas, A. Angew Chem., Int. Ed. Engl. 1981, 20, 647.
15. Beaman, A. G.; Robins, R. K. J. Org. Chem. 1963, 28, 2310.
16. Naik, S. R.; Witkowski, J. T.; Robins, R. K. J. Org. Chem. 1973, 38, 4353.
17. Ikehara, M.; Yamada, S. Chem. Pharm. Bull. 1971, 19, 104.
18. Kobayashi, Y.; Kumadaki, I.; Ohsawa, A.; Murakami, S. J. Chem. Soc., Chem. Commun. 1976, 430.
19. Sono, M.; Toyoda, N.; Shizuri, Y.; Tori, M. Tetrahedron Lett. 1994, 35, 9237.
20. Ratsep, P. C.; Robins, R. K.; Vaghefi, M. M. Nucleosides Nucleotides 1990, 9, 197 and references cited therein.
21. For a preliminary communication, see: Barrio, J. R.; Namavari, M.; Phelps, M. E.; Satyamurthy, N. J. Org. Chem. 1996, 61, 6084.
22. The chemistry of halides, pseudo-halides and azides; Patai, S., Rappoport, Z., Eds.; John Wiley and Sons: Chichester, U.K., 1995; Supplement D2 Part 1, p 629.
23. Rozen, S.; Gal, C.; Faust, Y. J. Am. Chem. Soc. 1980, 102, 6860.
24. With protected purines (1b,d,e,f), about 80% of the starting material was consumed under the conditions described in the Experimental Section. For reaction with purines la,c in EtOH, larger amounts of starting material could be recovered from the reaction mixture. Longer reaction times, however, revealed the formation of side products in detriment of the yield of the C(8)-fluorinated products. Also, solvents such as water and HOAc provided much lower yields than that observed in EtOH medium.
25. Shiue, C.-Y.; Salvadori, P. A.; Wolf, A. P.; Fowler, J. S.; MacGregor, R. R. J. Nucl. Med. 1982, 23, 899.
26. Reference 13, p 821.
27. Umemoto, T.; Fukami, S.; Tomizawa, G.; Harasawa, K; Kawada, K.; Tomita, K. J. J. Am. Chem. Soc. 1990, 112, 8563.
28. Lal, G. S. J. Org. Chem. 1993, 58, 2791.
29. See, for example: (a) Gal, C.; Rozen, S. Tetrahedron Lett. 1984, 25, 449. (b) Rozen, S.; Gal, C. J. Org. Chem. 1987, 52, 2769. (c) Rozen, S. Acc. Chem. Res. 1988, 21, 307. (d) Pross, A. Adv. Phys. Org. Chem. 1985, 21, 99.
30. See, for example: (a) Gal, C.; Rozen, S. Tetrahedron Lett. 1984, 25, 449. (b) Rozen, S.; Gal, C. J. Org. Chem. 1987, 52, 2769. (c) Rozen, S. Acc. Chem. Res. 1988, 21, 307. (d) Pross, A. Adv. Phys. Org. Chem. 1985, 21, 99.
31. See, for example: (a) Gal, C.; Rozen, S. Tetrahedron Lett. 1984, 25, 449. (b) Rozen, S.; Gal, C. J. Org. Chem. 1987, 52, 2769. (c) Rozen, S. Acc. Chem. Res. 1988, 21, 307. (d) Pross, A. Adv. Phys. Org. Chem. 1985, 21, 99.
32. See, for example: (a) Gal, C.; Rozen, S. Tetrahedron Lett. 1984, 25, 449. (b) Rozen, S.; Gal, C. J. Org. Chem. 1987, 52, 2769. (c) Rozen, S. Acc. Chem. Res. 1988, 21, 307. (d) Pross, A. Adv. Phys. Org. Chem. 1985, 21, 99.
33. Cech, D.; Holy, A. Collect. Czech. Chem. Commun. 1976, 41, 3335.
34. Purrington, S. T.; Kagen, B. S.; Patrick, T. B. Chem. Rev. 1986, 86, 997.
35. Grakauskas, V. J. Org. Chem. 1970, 35, 723.
36. Cacace, F.; Giacomello, P.; Wolf, A. P. J. Am. Chem. Soc. 1980, 102, 3511.
37. (a) Namavari, M.; Bishop, A.; Satyamurthy, N.; Bida, G. T.; Barrio, J. R. Appl. Radiat, Isot. 1992, 43, 989.
38. (b) Namavari, M.; Satyamurthy, N.; Phelps, M. E.; Barrio, J. R. Appl. Radiat. Isot. 1993, 44, 527.
39. (c) Satyamurthy, N.; Namavari, M.; Barrio, J. R. CHEMTECH 1994, 24, 25.
40. (d) Lacan, G.; Satyamurthy, N.; Barrio, J. R. J. Org. Chem. 1995, 60, 227.
41. Coenen, H. H.; Moerlein, S. M. J. Fluorine Chem. 1987, 36, 63.
42. See, for example: (a) Van Der Puy, M.; Nalewajek, D.; Wicks, G. E. Tetrahedron Lett. 1988, 29, 4389. (b) Kosower, E. M.; Hebel, D.; Rozen, S.; Radkowski, A. E. J. Org. Chem. 1985, 50, 4152. (c) Luxen, A.; Barrio, J. R.; Satyamurthy, N.; Bida, G. T.; Phelps, M. E. J. Fluorine Chem. 1987, 36, 83.
43. See, for example: (a) Van Der Puy, M.; Nalewajek, D.; Wicks, G. E. Tetrahedron Lett. 1988, 29, 4389. (b) Kosower, E. M.; Hebel, D.; Rozen, S.; Radkowski, A. E. J. Org. Chem. 1985, 50, 4152. (c) Luxen, A.; Barrio, J. R.; Satyamurthy, N.; Bida, G. T.; Phelps, M. E. J. Fluorine Chem. 1987, 36, 83.
44. See, for example: (a) Van Der Puy, M.; Nalewajek, D.; Wicks, G. E. Tetrahedron Lett. 1988, 29, 4389. (b) Kosower, E. M.; Hebel, D.; Rozen, S.; Radkowski, A. E. J. Org. Chem. 1985, 50, 4152. (c) Luxen, A.; Barrio, J. R.; Satyamurthy, N.; Bida, G. T.; Phelps, M. E. J. Fluorine Chem. 1987, 36, 83.
45. Bryce, M. R.; Chambers, R. D.: Mullins, S. T.; Parkin. A. Bull. Chim. Soc. Fr. 1986, 930.
46. Fused Pyrimidines. Brown, D. J., Ed.; Part II, Purines; Meister, J. H., Ed.; Wiley-Interscience: New York, 1971; Chapter V, p 135.
47. Mazzella, L. J.; Parkin, D. W.; Tyler, P. C.; Furneaux, R. H.; Schramm, V. L. J. Am. Chem. Soc. 1996, 118, 2111.
48. 9 (see the Experimental Section), (b) Hampton, A.; Harper, P. J.; Sasaki, T. Biochemistry 1972, 11, 4736. (c) Zemlicka, J. J. Am. Chem. Soc. 1975, 97, 5896. (d) Stolarski, R.; Pohorille, A.; Dudycz, L.; Shugar, D. Biochim. Biophys. Acta 1980, 610, 1.
49. 9 (see the Experimental Section), (b) Hampton, A.; Harper, P. J.; Sasaki, T. Biochemistry 1972, 11, 4736. (c) Zemlicka, J. J. Am. Chem. Soc. 1975, 97, 5896. (d) Stolarski, R.; Pohorille, A.; Dudycz, L.; Shugar, D. Biochim. Biophys. Acta 1980, 610, 1.
50. 9 (see the Experimental Section), (b) Hampton, A.; Harper, P. J.; Sasaki, T. Biochemistry 1972, 11, 4736. (c) Zemlicka, J. J. Am. Chem. Soc. 1975, 97, 5896. (d) Stolarski, R.; Pohorille, A.; Dudycz, L.; Shugar, D. Biochim. Biophys. Acta 1980, 610, 1.
51. 9 (see the Experimental Section), (b) Hampton, A.; Harper, P. J.; Sasaki, T. Biochemistry 1972, 11, 4736. (c) Zemlicka, J. J. Am. Chem. Soc. 1975, 97, 5896. (d) Stolarski, R.; Pohorille, A.; Dudycz, L.; Shugar, D. Biochim. Biophys. Acta 1980, 610, 1.
52. (a) Orozco, M.; Lluis, C.; Mallol, J.; Canela, E. I.; Franco, R. J. Pharm. Sci. 1990, 79, 133.
53. (b) Ikehara, M.; Uesugi, S.; Yoshida, K. Biochemisty 1972, 11, 830.
54. Fluorine has a small van der Waals radius (1.35 Å) which closely resembles that of hydrogen (1.2 A). See: Pauling, L. The Nature of the Chemical Bond, 3rd ed.; Cornell University Press: Ithaca, NY, 1960; p 260.
55. 19F NMR of nucleotides in these series. Specific influences of the phosphate-(s) on the sugar base torsion angle (XCN) have been recognized with purine nucleotides:
56. (a) Schweizer, M. P.; Broom, A. D.; Ts'o, P. O. P.; Hollis, D. P. J. Am. Chem. Soc. 1968, 90, 1042.
57. (b) Jardetzky, C. D.; Jardetzky, O. J. Am. Chem. Soc. 1960, 82, 222 and other nucleotide analogues,
58. (c) Barrio, J. R.; Liu, F.-T.; Keyser, G. E.; VanDer Lijn, P.; Leonard, N. J. J. Am. Chem. Soc. 1979, 101, 1564.
59. (a) Robins, M. J.; Hatfield, P. W.; Balzarini, J.; De Clercq, E. J. Med. Chem. 1984, 27, 1486.
60. (b) Gosselin, G.; Bergogne, M.-C.; De Rudder. J.; De Clercq, E.; Imbach, J.-L. J. Med. Chem. 1987, 30, 982.
61. 3): δ-108.2 ppm] consistent with unaltered 2c. Srinivasan, A.; Gambhir, S.; Barrio, J. R.; Wu, L.; Namavari, M.; Satyamurthy, N.; Sharfstein, S.; Cherry, S.; Green, A.; Berk, A.; Phelps, M. E.; Herschman, H.R. Submitted for publication in Science.
62. 18F is 109.7 min).
63. Matheson Gas Data Book; Braker, W., Mossman, A. L., Eds.; Matheson: East Rutherford, NJ, 1971; p 261.
64. Barrio, J. R.; Bryant, J. D.; Keyser, G. E. J. Med. Chem. 1980, 23, 572.
65. Gosselin, G.; Bergogne. M.-C.; Imbach, J.-L. J. Heterocycl. Chem. 1993, 30, 1229.
66. Matsumoto, H.; Kaneko, C.; Yamada, K.; Takeuchi, T.; Mori, T.; Mizuno, Y. Chem. Pharm. Bull. 1988, 36, 1153.
67. 2O, 60:36:4)). Optimum reaction times for product (2a,c) isolation varied from 2 to 5 h.